Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler ...

Myriad Genetics (NASDAQ:MYGN) traded higher on Wednesday after Piper Sandler upgraded the cancer test developer to Overweight ...

Fintel reports that on March 12, 2025, Piper Sandler upgraded their outlook for Myriad Genetics (NasdaqGS:MYGN) from Neutral ...

A new study from Oxford Population Health has revealed that lifestyle choices and environmental factors have a much bigger ...

Gene Hackman and Betsy Arakawa's time of death have become crucial before their will and inheritance reveal. A 120 hours law plays significant role with respect to what may happen of their estate. If ...

The tragic deaths of legendary actor Gene Hackman and his wife, Betsy Arakawa, have left significant legal questions ...

The Genes, Systems and Computation Seminar (GSC) series is jointly run by the Institute for Systems Genetics (ISG) and the ...

Dogs are a good model for studying human obesity because they develop obesity through similar environmental influences as ...

引言你是否想过，那些宣称能预测疾病风险的基因检测，可能混淆了家族传承与天生基因？3月10日发表于《Nature Genetics》的研究“Family-based genome-wide association study designs for ...

周三，Piper Sandler分析师Dave Westenberg将Myriad Genetics的评级从"中性"上调至"增持"，并将目标价从此前的11.50美元上调至12.50美元。根据 InvestingPro 数据显示，分析师对该股票的目标价区间为11美元至29美元，Westenberg的新目标价处于较为保守的范围内。在过去六个月里，该股票下跌了61.16%，目前交易价格为10.25美元。

在充满挑战的市场环境下，Atossa Genetics Inc.（ATOS）股价已触及52周新低，交易价格为0.7美元。根据 InvestingPro 数据显示，该公司保持强劲的流动性状况，流动比率为13.3，而分析师目标价区间为4美元至7美元。这一最新价格凸显了这家生物制药公司经历的重大波动期，其股价在过去一年下跌了43.45%。投资者正密切关注Atossa ...

Gene editing has taken root in plant breeding, leading to numerous advances in plant-based foods. K-State scientists, for ...